Mindmed announces new employee inducement grants

New york--(business wire)--mind medicine (mindmed) inc. (nasdaq: mnmd) (the “company” or “mindmed”), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the issuance of inducement grants to four newly hired non-executive employees consisting of options to purchase an aggregate of 171,000 common shares of the company (the "options"), with effective grant dates of november 18, 2024 and december 2, 2024, depending on the a.
MNMD Ratings Summary
MNMD Quant Ranking